Critical Care Perspectives in Emergency Medicine

Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Brought to you by Critical Care Perspectives in Emergency Medicine of Critical Care Perspectives in Emergency Medicine